Erratum: The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy (Cancer Gene Therapy (2012) 19 (382-392) DOI: 10.1038/cgt.2012.11);The radiation dose-regulated and gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy

Cancer Gene Therapy

Volumn 19, Issue 6, 2012, Pages 382-392

  Ding, M ^a   Zhang, E ^b   He, R ^c   Wang, X ^c   Li, R ^b   Wang, W ^c   Yi, Q ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Radiation Oncology   (China)

Author keywords

AND gate; hypoxia; ionizing radiation; targeted gene therapy

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

AND GATE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER PATIENT; CELL CYCLE ARREST; CONTROLLED STUDY; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONITORING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; REGULATORY MECHANISM; SOLID TUMOR; TUMOR CELL; TUMOR XENOGRAFT;

EID: 84861193659     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.43     Document Type: Erratum

References (30)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun JM. Cancer statistics. CA-Cancer J Clin 2009; 59: 225-249.
2. Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Fléjou JF et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011; 17: 827-835.
3. Barnett GC, West CML, Dunning AM, Elliott RM, Coles CE, Pharoah PDP et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 2009; 9: 134-142.
4. Henŕquez-Hernández LA, Bordón E, Pinar B, Lloret M, Rodŕguez-Gallego C, Lara PC. Prediction of normal tissue toxicity as part of the individualized treatment with radiotherapy in oncology patients. Surg Oncol 2012 (in press).
5. Abdollahi A, Folkman J. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy. Drug Resist Updat 2010; 13: 16-28.
6. Velez JM, Miriyala S, Nithipongvanitch R, Noel T, Plabplueng CD, Oberley T et al. p53 regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury. PLoS ONE 2011; 6: e18005.
7. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15: 360-371.
8. Lo HW, Day CP, Hung MC. Cancer-specific gene therapy. Adv Genet 2005; 54: 235-255.
9. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347-361. (Pubitemid 38340304)
10. Stewart GD, Nanda J, Katz E, Bowman KJ, Christie JG, Brown DJG et al. DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions. Biochem Pharmacol 2011; 81: 203-210.
11. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol 2004; 59: 928-942. (Pubitemid 38834285)
12. Martin JB. Tumor hypoxia in cancer therapy. Methods Enzymol 2007; 435: 295-321.
13. Hockel M, Vaupel P. Biological consequences of tumor hypoxia. Semin Oncol 2001; 28: 36-41. (Pubitemid 32522236)
14. Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD. Hypoxia-and radiation-activated Cre//loxP 'molecular switch' vectors for gene therapy of cancer. Gene Ther 2005; 13: 206-215.
15. Wang W, Chen Z, Li R, Li D, Duan Y, Cao Z. Enhanced efficacy of radiation-induced gene therapy in mice bearing lung adenocarcinoma xenografts using hypoxia responsive elements. Cancer Sci 2005; 96: 918-924. (Pubitemid 43056132)
16. Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther 2002; 9: 1403-1411. (Pubitemid 35244166)
17. Mayr NA, Huang Z, Sohn JW, Lo SS, Teh BS, Lu JJ et al. Emerging application of stereotactic body radiation therapy for gynecologic malignancies. Expert Rev Anticancer 2011; 11: 1071-1077.
18. Vujaskovic Z, Willett CG, Tepper JE, Kinsella TJ, Gunderson LL. Normal-tissue tolerance to IOERT, EBRT, or both: animal and clinical studies. In: Gunderson LL, Willett CG, Calvo FA, Harrison LB (eds). Current Clinical Oncology, 2nd edn. Humana Press: Totowa, 2011, pp 119-138.
19. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol 2008; 70: 1124-1129. (Pubitemid 351296130)
20. Maingon P, Marchesi V, Crehange G. Intensity modulated radiation therapy. Br J Cancer 2010; 97: 759-768.
21. Yu ST, Li C, Lu MH, Liang GP, Li N, Tang XD et al. Noninvasive and real-time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter. Cancer 2012; 118: 1884-1893.
22. Asano S. Gene therapy as translational research. Mol Urol 2000; 4: 41. (Pubitemid 30413636)
23. Chang Q, Jurisica I, Do T, Hedley DW. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer. Cancer Res 2011; 71: 3110-3120.
24. Ammoun S, Zhou L, Barczyk M, Hilton D, Hafizi S, Hanemann C et al. Gas6/axlfamily receptors in schwannoma pathological proliferation, adhesion and survival. Neuro Oncol 2011; 13: 1-14.
25. Crosby ME, Kulshreshtha R, Ivan M, Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 2009; 69: 1221-1229.
26. Avalosse B, Dupont F, Burny A. Gene therapy for cancer. Curr Opin Oncol 1995; 7: 94-100.
27. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003; 101: 2099-2113.
28. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML, Nanomato et al. Adenovirus mediated cancer gene therapy and virotherapy. Int J Mol Med 2010; 25: 3-10.
29. Wang W, Li R, Chen Z, Li D, Duan Y, Cao Z. Cisplatin-controlled p53 gene therapy for human non-small cell lung cancer xenografts in athymic nude mice via the CArG elements. Cancer Sci 2005; 96: 706-712. (Pubitemid 41723548)
30. Pines A, Bivi N, Romanello M, Damante G, Kelley MR, Adamson ED et al. Crossregulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop. Free Radical Res 2005; 39: 269-281. (Pubitemid 40439389)